J Autoimmun

• 

  Publication Venue For

  • Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer..  115:102546. 2020
  • Evolving story of autoantibodies in systemic lupus erythematosus..  110:102356. 2020
  • Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model..  106:102332. 2020
  • Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes..  102:142-149. 2019
  • Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis..  59:43-52. 2015
  • Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'..  59:8-18. 2015
  • Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis..  52:130-138. 2014
  • STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib..  46:25-34. 2013
  • The eye: A window to the soul of the immune system..  45:7-14. 2013
  • Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading..  39:347-353. 2012
  • CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients..  38:10-19. 2012
  • Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus..  36:173-180. 2011
  • B cells contribute to ischemia/reperfusion-mediated tissue injury..  32:195-200. 2009
  • Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases..  33:197-207. 2009
  • Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid..  27:196-202. 2006